首页 > 最新文献

Journal of Evidence‐Based Medicine最新文献

英文 中文
The risk of HIV transmission based on viral load in serodiscordant heterosexual partners receiving antiretroviral therapy: An umbrella review. 在接受抗逆转录病毒治疗的血清不一致异性伴侣中,基于病毒载量的HIV传播风险:一项综述。
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-07 DOI: 10.1111/jebm.12564
Castory G Munishi, Belinda J Njiro, Harrieth P Ndumwa, David T Myemba, Emmanuel Mang'ombe, George M Bwire
{"title":"The risk of HIV transmission based on viral load in serodiscordant heterosexual partners receiving antiretroviral therapy: An umbrella review.","authors":"Castory G Munishi, Belinda J Njiro, Harrieth P Ndumwa, David T Myemba, Emmanuel Mang'ombe, George M Bwire","doi":"10.1111/jebm.12564","DOIUrl":"10.1111/jebm.12564","url":null,"abstract":"","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138498583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
General anesthesia versus nongeneral anesthesia during endovascular therapy for acute ischemic stroke: A systematic review and meta-analysis. 急性缺血性脑卒中血管内治疗中的全身麻醉与非全身麻醉:系统回顾和荟萃分析。
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-21 DOI: 10.1111/jebm.12569
Xinyan Wang, Youxuan Wu, Fa Liang, Hongqiu Gu, Minyu Jian, Yunzhen Wang, Haiyang Liu, Ruquan Han

Objective: This study compares the safety and efficacy of general anesthesia (GA) and nongeneral anesthesia (non-GA) on functional outcomes in patients receiving endovascular therapy for ischemic stroke.

Methods: All available studies on the anesthetic management of patients with acute ischemic stroke in PubMed, the Cochrane Central Register of Controlled Trials, and Embase were included. We also compared the clinical outcomes in the studies with subgroup analyses of the occlusion site (anterior vs. posterior circulation) and preretriever group versus retriever group. Functional independence, mortality, successful recanalization, hemodynamic instability, intracerebral hemorrhage, and respiratory complications were considered primary or secondary outcomes.

Results: A total of 24,606 patients in 60 studies were included. GA had a lower risk of 90-day functional independence (OR = 0.67, 95% CI 0.58 to 0.77), higher risk of 90-day mortality (OR = 1.29; 95% CI 1.15 to 1.45), and successful reperfusion (OR = 1.18; 95% CI 1.94 to 6.82). However, there were no differences in functional independence and mortality between GA and non-GA at 90 days after the procedure.

Conclusion: The study shows poorer results in the GA group, which may be due to the inclusion of nonrandomized studies. However, analysis of the RCTs suggested that the outcomes do not differ between the two groups (GA vs. non-GA). Thus, general anesthesia is as safe as nongeneral anesthesia under standardized management.

目的本研究比较了全身麻醉(GA)和非全身麻醉(non-GA)对缺血性脑卒中血管内治疗患者功能预后的安全性和有效性:方法:纳入 PubMed、Cochrane Central Register of Controlled Trials 和 Embase 中所有关于急性缺血性脑卒中患者麻醉管理的研究。我们还比较了这些研究的临床结果,并对闭塞部位(前循环与后循环)和预吸入器组与吸入器组进行了亚组分析。功能独立性、死亡率、成功再通、血流动力学不稳定、脑内出血和呼吸系统并发症被视为主要或次要结果:结果:共纳入了 60 项研究中的 24,606 名患者。GA的90天功能独立风险较低(OR = 0.67,95% CI 0.58至0.77),90天死亡风险较高(OR = 1.29;95% CI 1.15至1.45),再灌注成功的风险较低(OR = 1.18;95% CI 1.94至6.82)。然而,在术后90天,GA和非GA在功能独立性和死亡率方面没有差异:研究显示,GA组的结果较差,这可能是由于纳入了非随机研究。然而,对研究性临床试验的分析表明,两组(GA 组和非 GA 组)的结果并无差异。因此,在标准化管理下,全身麻醉与非全身麻醉一样安全。
{"title":"General anesthesia versus nongeneral anesthesia during endovascular therapy for acute ischemic stroke: A systematic review and meta-analysis.","authors":"Xinyan Wang, Youxuan Wu, Fa Liang, Hongqiu Gu, Minyu Jian, Yunzhen Wang, Haiyang Liu, Ruquan Han","doi":"10.1111/jebm.12569","DOIUrl":"10.1111/jebm.12569","url":null,"abstract":"<p><strong>Objective: </strong>This study compares the safety and efficacy of general anesthesia (GA) and nongeneral anesthesia (non-GA) on functional outcomes in patients receiving endovascular therapy for ischemic stroke.</p><p><strong>Methods: </strong>All available studies on the anesthetic management of patients with acute ischemic stroke in PubMed, the Cochrane Central Register of Controlled Trials, and Embase were included. We also compared the clinical outcomes in the studies with subgroup analyses of the occlusion site (anterior vs. posterior circulation) and preretriever group versus retriever group. Functional independence, mortality, successful recanalization, hemodynamic instability, intracerebral hemorrhage, and respiratory complications were considered primary or secondary outcomes.</p><p><strong>Results: </strong>A total of 24,606 patients in 60 studies were included. GA had a lower risk of 90-day functional independence (OR = 0.67, 95% CI 0.58 to 0.77), higher risk of 90-day mortality (OR = 1.29; 95% CI 1.15 to 1.45), and successful reperfusion (OR = 1.18; 95% CI 1.94 to 6.82). However, there were no differences in functional independence and mortality between GA and non-GA at 90 days after the procedure.</p><p><strong>Conclusion: </strong>The study shows poorer results in the GA group, which may be due to the inclusion of nonrandomized studies. However, analysis of the RCTs suggested that the outcomes do not differ between the two groups (GA vs. non-GA). Thus, general anesthesia is as safe as nongeneral anesthesia under standardized management.</p>","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138830130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of post-traumatic stress disorder (PTSD) in elderly survivors of the Wenchuan earthquake: A cross-sectional study. 汶川地震老年幸存者创伤后应激障碍(PTSD)的评估:一项横断面研究。
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-10-05 DOI: 10.1111/jebm.12557
Yang Peng, Bingqing Lu, Jin Wen

Objective: Post-traumatic stress disorder (PTSD) is a prevalent condition characterized by prolonged psychological distress following traumatic events encompassing serious health threats, domestic abuse, and natural disasters. The onset and persistence of PTSD can be attributed to advanced age. This study aimed to explore the occurrence and influencing factors of enduring post-traumatic stress disorder (PTSD) in survivors aged 60 years and over in the main area of the 2008 Wenchuan earthquake 10 years after the disaster.

Methods: Data were collected using a multistage sampling method from individuals aged 60 years and older living in the main impacted areas of Wenchuan 10 years after the Wenchuan earthquake. The PTSD Checklist-Civilian Version (PCL-C) was used to evaluate PTSD symptoms. We evaluated participants based on their PTSD symptoms: those exhibiting and those without. The latter group was four times the size of the former and was matched based on gender and age (within ± 2 years). Conditional logistic regression was used to discern the risk factors.

Results: Out of the total, 56 participants were recognized as having probable PTSD as per the PCL-C checklist, leading to a rate of 9.4% (56/588). The univariate conditional logistic regression values showed that playing Mahjong/poker (odds ratio (OR) = 0.394, 95% confidence interval (CI) = 0.171-0.911) and displacement (OR = 0.446, 95% CI = 0.220-0.907) were protective factors for the long-term mental health of survivors in the hard-hit areas, while the presence of a 2-week illness (OR = 3.605, 95% CI = 1.751-7.424), possessing insurance (OR = 0.250, 95% CI = 0.072-0.864), suffering from a chronic ailment (OR = 3.132, 95% CI = 1.2-8.174), and having an injured family member (OR = 2.26, 95% CI = 1.136-4.496) emerged as risk factors for PTSD symptoms. Multivariate analysis indicated that the absence of insurance and prevalence of 2-week illness correlated with increased PTSD symptoms.

Conclusions: Ten years after the Wenchuan earthquake, the prevalence of probable PTSD remained significantly high in the elderly population. The major risk factors were the absence of insurance and the occurrence of a 2-week illness. Policymakers should incorporate these findings when devising strategies for aging societies.

目的:创伤后应激障碍(PTSD)是一种常见的疾病,其特征是在包括严重健康威胁、家庭虐待和自然灾害在内的创伤事件后持续的心理困扰。创伤后应激障碍的发作和持续可归因于高龄。本研究旨在探讨2008年汶川大地震灾区60岁及以上幸存者在灾后10年持久性创伤后应激障碍(PTSD)的发生及其影响因素。方法:采用多阶段抽样方法,对汶川地震10年后生活在汶川主要受灾地区的60岁及以上人群进行数据采集。PTSD检查表平民版(PCL-C)用于评估PTSD症状。我们根据参与者的创伤后应激障碍症状对他们进行了评估:表现出创伤后应激症状的和没有表现出的。后一组的体型是前一组的四倍,根据性别和年龄进行匹配(±2岁以内)。采用条件logistic回归分析危险因素。结果:根据PCL-C检查表,在总共56名参与者中,有56人被认为可能患有创伤后应激障碍,患病率为9.4%(56/588)。单变量条件logistic回归值显示,打麻将/扑克(比值比(OR)=0.394,95%置信区间(CI)=0.171-0.911)和流离失所(OR=0.446,95%CI=0.220-0.907)是重灾区幸存者长期心理健康的保护因素,拥有保险(OR=0.250,95%CI=0.072-0.864)、患有慢性病(OR=3.132,95%CI=1.2-8.174)和有受伤的家庭成员(OR=2.26,95%CI=1.136-4.496)成为PTSD症状的风险因素。多因素分析表明,没有保险和2周患病率与PTSD症状增加相关。结论:汶川地震发生10年后,老年人群中PTSD的患病率仍然很高。主要的风险因素是没有保险和发生2周的疾病。政策制定者在制定老龄化社会的战略时,应该将这些发现纳入其中。
{"title":"Assessment of post-traumatic stress disorder (PTSD) in elderly survivors of the Wenchuan earthquake: A cross-sectional study.","authors":"Yang Peng, Bingqing Lu, Jin Wen","doi":"10.1111/jebm.12557","DOIUrl":"10.1111/jebm.12557","url":null,"abstract":"<p><strong>Objective: </strong>Post-traumatic stress disorder (PTSD) is a prevalent condition characterized by prolonged psychological distress following traumatic events encompassing serious health threats, domestic abuse, and natural disasters. The onset and persistence of PTSD can be attributed to advanced age. This study aimed to explore the occurrence and influencing factors of enduring post-traumatic stress disorder (PTSD) in survivors aged 60 years and over in the main area of the 2008 Wenchuan earthquake 10 years after the disaster.</p><p><strong>Methods: </strong>Data were collected using a multistage sampling method from individuals aged 60 years and older living in the main impacted areas of Wenchuan 10 years after the Wenchuan earthquake. The PTSD Checklist-Civilian Version (PCL-C) was used to evaluate PTSD symptoms. We evaluated participants based on their PTSD symptoms: those exhibiting and those without. The latter group was four times the size of the former and was matched based on gender and age (within ± 2 years). Conditional logistic regression was used to discern the risk factors.</p><p><strong>Results: </strong>Out of the total, 56 participants were recognized as having probable PTSD as per the PCL-C checklist, leading to a rate of 9.4% (56/588). The univariate conditional logistic regression values showed that playing Mahjong/poker (odds ratio (OR) = 0.394, 95% confidence interval (CI) = 0.171-0.911) and displacement (OR = 0.446, 95% CI = 0.220-0.907) were protective factors for the long-term mental health of survivors in the hard-hit areas, while the presence of a 2-week illness (OR = 3.605, 95% CI = 1.751-7.424), possessing insurance (OR = 0.250, 95% CI = 0.072-0.864), suffering from a chronic ailment (OR = 3.132, 95% CI = 1.2-8.174), and having an injured family member (OR = 2.26, 95% CI = 1.136-4.496) emerged as risk factors for PTSD symptoms. Multivariate analysis indicated that the absence of insurance and prevalence of 2-week illness correlated with increased PTSD symptoms.</p><p><strong>Conclusions: </strong>Ten years after the Wenchuan earthquake, the prevalence of probable PTSD remained significantly high in the elderly population. The major risk factors were the absence of insurance and the occurrence of a 2-week illness. Policymakers should incorporate these findings when devising strategies for aging societies.</p>","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41179037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The SHARE: SHam Acupuncture REporting guidelines and a checklist in clinical trials. 分享:SHam针灸移植指南和临床试验检查表。
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-10-31 DOI: 10.1111/jebm.12560
Peihong Ma, Xiaoyu Liu, Zhishun Liu, Yi Guo, Kehua Zhou, Zhaoxiang Bian, Chengyi Sun, Tinglan Liu, Zhiyi Xiong, Yixuan Xie, Ying Lu, Lixing Lao, Liyun He, Baoyan Liu, Cunzhi Liu, Shiyan Yan
{"title":"The SHARE: SHam Acupuncture REporting guidelines and a checklist in clinical trials.","authors":"Peihong Ma, Xiaoyu Liu, Zhishun Liu, Yi Guo, Kehua Zhou, Zhaoxiang Bian, Chengyi Sun, Tinglan Liu, Zhiyi Xiong, Yixuan Xie, Ying Lu, Lixing Lao, Liyun He, Baoyan Liu, Cunzhi Liu, Shiyan Yan","doi":"10.1111/jebm.12560","DOIUrl":"10.1111/jebm.12560","url":null,"abstract":"","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71412544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guideline on Establishing Diagnostic Criteria for Chinese Medicine Syndromes. 制定中医综合征诊断标准指南》。
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-21 DOI: 10.1111/jebm.12572
Jiansheng Li, Yang Xie, Liu Chun, Zhiwan Wang

Aim: To formulate the guideline for the development of diagnostic criteria for Chinese medicine syndromes, which can contribute to standardization of development of Chinese medicine syndrome diagnostic standards.

Methods: We embark into account on the development of Guideline on Establishing Diagnostic Criteria for Chinese Medicine Syndromes through Delphi method with reference to the existing technical system of diagnostic criteria for Chinese medicine syndromes and relevant criteria.

Results: Our guideline specifies principles, methods, and procedures for the formulation of diagnostic criteria for Chinese medicine syndromes.

Conclusions: It is a comprehensive and systematic evidence-based guideline, and we hope this guideline can be applied as a reference in developing diagnostic criteria for Chinese medicine syndromes in other disciplines. It is also applicable to the formulation of diagnostic criteria for relevant clinical, educational, and scientific research by hospitals, institutes, and academies.

目的:制定中医证候诊断标准指南,促进中医证候诊断标准的规范化发展:方法:参考现有中医证候诊断标准技术体系及相关标准,采用德尔菲法制定《中医证候诊断标准制定指南》:结果:我们的指南明确了中医综合征诊断标准制定的原则、方法和程序:这是一份全面、系统的循证指南,希望能为其他学科制定中医证候诊断标准提供参考。本指南也适用于医院、研究所和学术机构制定相关临床、教学和科研的诊断标准。
{"title":"Guideline on Establishing Diagnostic Criteria for Chinese Medicine Syndromes.","authors":"Jiansheng Li, Yang Xie, Liu Chun, Zhiwan Wang","doi":"10.1111/jebm.12572","DOIUrl":"10.1111/jebm.12572","url":null,"abstract":"<p><strong>Aim: </strong>To formulate the guideline for the development of diagnostic criteria for Chinese medicine syndromes, which can contribute to standardization of development of Chinese medicine syndrome diagnostic standards.</p><p><strong>Methods: </strong>We embark into account on the development of Guideline on Establishing Diagnostic Criteria for Chinese Medicine Syndromes through Delphi method with reference to the existing technical system of diagnostic criteria for Chinese medicine syndromes and relevant criteria.</p><p><strong>Results: </strong>Our guideline specifies principles, methods, and procedures for the formulation of diagnostic criteria for Chinese medicine syndromes.</p><p><strong>Conclusions: </strong>It is a comprehensive and systematic evidence-based guideline, and we hope this guideline can be applied as a reference in developing diagnostic criteria for Chinese medicine syndromes in other disciplines. It is also applicable to the formulation of diagnostic criteria for relevant clinical, educational, and scientific research by hospitals, institutes, and academies.</p>","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138830131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An online hepatitis C virus self-sampling strategy for gay, bisexual, and other men who have sex with men and trans women: TESTATE C PLUS 2020-2021. 针对男同性恋、双性恋及其他男男性行为者和变性女性的在线丙型肝炎病毒自我采样策略:TESTATE C PLUS 2020-2021。
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-25 DOI: 10.1111/jebm.12566
Héctor Martínez-Riveros, Elisa Martró, Marcos Montoro-Fernandez, Yesika Diaz, Esteve Muntada, Pol Romano-deGea, Sergio Moreno-Fornés, Rubén Mora, Luis Villegas, Juan Mena, Quim Roqueta, Juanse Hernández, Miguel Vázquez, Cristina Rius, Francisca Román, Anna Not, Laura Muntané, Joan Colom, Jordi Casabona, Cristina Agustí
{"title":"An online hepatitis C virus self-sampling strategy for gay, bisexual, and other men who have sex with men and trans women: TESTATE C PLUS 2020-2021.","authors":"Héctor Martínez-Riveros, Elisa Martró, Marcos Montoro-Fernandez, Yesika Diaz, Esteve Muntada, Pol Romano-deGea, Sergio Moreno-Fornés, Rubén Mora, Luis Villegas, Juan Mena, Quim Roqueta, Juanse Hernández, Miguel Vázquez, Cristina Rius, Francisca Román, Anna Not, Laura Muntané, Joan Colom, Jordi Casabona, Cristina Agustí","doi":"10.1111/jebm.12566","DOIUrl":"10.1111/jebm.12566","url":null,"abstract":"","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139037793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aspirin for prevention of cardiovascular disease in patients with high levels of lipoprotein(a): Evidence from two-sample Mendelian randomization analysis. 阿司匹林预防高脂蛋白患者心血管疾病(a):来自双样本孟德尔随机化分析的证据
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-04 DOI: 10.1111/jebm.12562
Jiang-Shan Tan, Wei Xu, Jingyang Wang, Tianqi Li, Lulu Wang, Jun Zhu, Yanmin Yang
{"title":"Aspirin for prevention of cardiovascular disease in patients with high levels of lipoprotein(a): Evidence from two-sample Mendelian randomization analysis.","authors":"Jiang-Shan Tan, Wei Xu, Jingyang Wang, Tianqi Li, Lulu Wang, Jun Zhu, Yanmin Yang","doi":"10.1111/jebm.12562","DOIUrl":"10.1111/jebm.12562","url":null,"abstract":"","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138477877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advancement in integrating artificial intelligence and information technology with real-world data for clinical decision-making in China: A scoping review. 中国将人工智能和信息技术与现实世界数据相结合用于临床决策的最新进展:范围界定综述。
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-09-29 DOI: 10.1111/jebm.12549
Xiwen Liao, Chen Yao, Jun Zhang, Larry Z Liu

Objective: Striking innovations and advancements have been achieved with the use of artificial intelligence and healthcare information technology being integrated into clinical real-world data. The current scoping review aimed to provide an overview of the current status of artificial intelligence-/information technology-based clinical decision support tools in China.

Methods: PubMed/MEDLINE, Embase, China National Knowledge Internet, and Wanfang data were searched for both English and Chinese literature. The gray literature search was conducted for commercially available tools. Original studies that focused on clinical decision support tools driven by artificial intelligence or information technology in China and were published between 2010 and February 2022 were included. Information extracted from each article was further synthesized by themes based on three types of clinical decision-making.

Results: A total of 37 peer-reviewed publications and 13 commercially available tools were included in the final analysis. Among them, 32.0% were developed for disease diagnosis, 54.0% for risk prediction and classification, and 14.0% for disease management. Chronic diseases were the most popular therapeutic areas of exploration, with particular emphasis on cardiovascular and cerebrovascular diseases. Single-center electronic medical records were the mainstream data sources leveraged to inform clinical decision-making, with internal validation being predominately used for model evaluation.

Conclusions: To effectively promote the extensive use of real-world data and drive a paradigm shift in clinical decision-making in China, multidisciplinary collaboration of key stakeholders is urgently needed.

目标:通过将人工智能和医疗保健信息技术集成到临床真实世界数据中,实现了惊人的创新和进步。目前的范围综述旨在概述中国基于人工智能/信息技术的临床决策支持工具的现状。方法:检索PubMed/MEDLINE、Embase、中国国家知识互联网和万方数据,检索中英文文献。灰色文献搜索是为了寻找商业上可用的工具。纳入了2010年至2022年2月期间发表的专注于中国人工智能或信息技术驱动的临床决策支持工具的原始研究。根据三种类型的临床决策,按主题进一步综合从每篇文章中提取的信息。结果:共有37篇同行评审出版物和13种商用工具被纳入最终分析。其中,32.0%用于疾病诊断,54.0%用于风险预测和分类,14.0%用于疾病管理。慢性病是最受欢迎的治疗领域,尤其是心脑血管疾病。单中心电子病历是为临床决策提供信息的主流数据来源,内部验证主要用于模型评估。结论:为了有效促进真实世界数据的广泛使用,并推动中国临床决策的范式转变,迫切需要关键利益相关者的多学科合作。
{"title":"Recent advancement in integrating artificial intelligence and information technology with real-world data for clinical decision-making in China: A scoping review.","authors":"Xiwen Liao, Chen Yao, Jun Zhang, Larry Z Liu","doi":"10.1111/jebm.12549","DOIUrl":"10.1111/jebm.12549","url":null,"abstract":"<p><strong>Objective: </strong>Striking innovations and advancements have been achieved with the use of artificial intelligence and healthcare information technology being integrated into clinical real-world data. The current scoping review aimed to provide an overview of the current status of artificial intelligence-/information technology-based clinical decision support tools in China.</p><p><strong>Methods: </strong>PubMed/MEDLINE, Embase, China National Knowledge Internet, and Wanfang data were searched for both English and Chinese literature. The gray literature search was conducted for commercially available tools. Original studies that focused on clinical decision support tools driven by artificial intelligence or information technology in China and were published between 2010 and February 2022 were included. Information extracted from each article was further synthesized by themes based on three types of clinical decision-making.</p><p><strong>Results: </strong>A total of 37 peer-reviewed publications and 13 commercially available tools were included in the final analysis. Among them, 32.0% were developed for disease diagnosis, 54.0% for risk prediction and classification, and 14.0% for disease management. Chronic diseases were the most popular therapeutic areas of exploration, with particular emphasis on cardiovascular and cerebrovascular diseases. Single-center electronic medical records were the mainstream data sources leveraged to inform clinical decision-making, with internal validation being predominately used for model evaluation.</p><p><strong>Conclusions: </strong>To effectively promote the extensive use of real-world data and drive a paradigm shift in clinical decision-making in China, multidisciplinary collaboration of key stakeholders is urgently needed.</p>","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41135636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical evaluation of established risk prediction models for acute respiratory distress syndrome in adult patients: A systematic review and meta-analysis. 成年患者急性呼吸窘迫综合征风险预测模型的关键评价:系统回顾和荟萃分析。
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-06 DOI: 10.1111/jebm.12565
Tao Wei, Siyi Peng, Xuying Li, Jinhua Li, Mengdan Gu, Xiaoling Li

Aim: To assess the performance of validated prediction models for acute respiratory distress syndrome (ARDS) by systematic review and meta-analysis.

Methods: Eight databases (Medline, CINAHL, Embase, The Cochrane Library, CNKI, WanFang Data, Sinomed, and VIP) were searched up to March 26, 2023. Studies developed and validated a prediction model for ARDS in adult patients were included. Items on study design, incidence, derivation methods, predictors, discrimination, and calibration were collected. The risk of bias was assessed by the Prediction model Risk of Bias Assessment Tool. Models with a reported area under the curve of the receiver operating characteristic (AUC) metric were analyzed.

Results: A total of 25 studies were retrieved, including 48 unique prediction models. Discrimination was reported in all studies, with AUC ranging from 0.701 to 0.95. Emerged AUC value of the logistic regression model was 0.837 (95% CI: 0.814 to 0.859). Besides, the value in the ICU group was 0.856 (95% CI: 0.812 to 0.899), the acute pancreatitis group was 0.863 (95% CI: 0.844 to 0.882), and the postoperation group was 0.835 (95% CI: 0.808 to 0.861). In total, 24 of the included studies had a high risk of bias, which was mostly due to the improper methods in predictor screening (13/24), model calibration assessment (9/24), and dichotomization of continuous predictors (6/24).

Conclusions: This study shows that most prediction models for ARDS are at high risk of bias, and the discrimination ability of the model is excellent. Adherence to standardized guidelines for model development is necessary to derive a prediction model of value to clinicians.

目的:通过系统回顾和荟萃分析,评价经验证的急性呼吸窘迫综合征(ARDS)预测模型的性能。方法:检索截至2023年3月26日的8个数据库(Medline, CINAHL, Embase, The Cochrane Library, CNKI, WanFang Data, Sinomed, VIP)。研究开发并验证了成人ARDS患者的预测模型。收集了有关研究设计、发生率、推导方法、预测因子、鉴别和校准的项目。偏倚风险通过预测模型偏倚风险评估工具进行评估。对具有报告的接收器工作特性(AUC)度量曲线下面积的模型进行了分析。结果:共检索到25篇研究,包括48个独特的预测模型。所有研究均存在歧视,AUC范围为0.701 ~ 0.95。logistic回归模型的出现AUC值为0.837 (95% CI: 0.814 ~ 0.859)。ICU组为0.856 (95% CI: 0.812 ~ 0.899),急性胰腺炎组为0.863 (95% CI: 0.844 ~ 0.882),术后组为0.835 (95% CI: 0.808 ~ 0.861)。共纳入24项研究存在高偏倚风险,主要原因是预测因子筛选(13/24)、模型校准评估(9/24)和连续预测因子二分类(6/24)方法不当。结论:本研究显示大多数ARDS预测模型存在较高的偏倚风险,模型的判别能力较好。为了得到一个对临床医生有价值的预测模型,必须遵守模型开发的标准化指南。
{"title":"Critical evaluation of established risk prediction models for acute respiratory distress syndrome in adult patients: A systematic review and meta-analysis.","authors":"Tao Wei, Siyi Peng, Xuying Li, Jinhua Li, Mengdan Gu, Xiaoling Li","doi":"10.1111/jebm.12565","DOIUrl":"10.1111/jebm.12565","url":null,"abstract":"<p><strong>Aim: </strong>To assess the performance of validated prediction models for acute respiratory distress syndrome (ARDS) by systematic review and meta-analysis.</p><p><strong>Methods: </strong>Eight databases (Medline, CINAHL, Embase, The Cochrane Library, CNKI, WanFang Data, Sinomed, and VIP) were searched up to March 26, 2023. Studies developed and validated a prediction model for ARDS in adult patients were included. Items on study design, incidence, derivation methods, predictors, discrimination, and calibration were collected. The risk of bias was assessed by the Prediction model Risk of Bias Assessment Tool. Models with a reported area under the curve of the receiver operating characteristic (AUC) metric were analyzed.</p><p><strong>Results: </strong>A total of 25 studies were retrieved, including 48 unique prediction models. Discrimination was reported in all studies, with AUC ranging from 0.701 to 0.95. Emerged AUC value of the logistic regression model was 0.837 (95% CI: 0.814 to 0.859). Besides, the value in the ICU group was 0.856 (95% CI: 0.812 to 0.899), the acute pancreatitis group was 0.863 (95% CI: 0.844 to 0.882), and the postoperation group was 0.835 (95% CI: 0.808 to 0.861). In total, 24 of the included studies had a high risk of bias, which was mostly due to the improper methods in predictor screening (13/24), model calibration assessment (9/24), and dichotomization of continuous predictors (6/24).</p><p><strong>Conclusions: </strong>This study shows that most prediction models for ARDS are at high risk of bias, and the discrimination ability of the model is excellent. Adherence to standardized guidelines for model development is necessary to derive a prediction model of value to clinicians.</p>","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138498582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of magnetic resonance imaging prognostic factors on neoadjuvant therapy in T3 or N+ rectal cancer: A retrospective cohort study. 磁共振成像预后因素对 T3 或 N+ 直肠癌新辅助治疗的影响:一项回顾性队列研究
IF 7.3 2区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-12-05 DOI: 10.1111/jebm.12567
Hao Xie, Ziwei Zeng, Yonghua Cai, Decai Ma, Dongxu Lei, Fujin Ye, Shuangling Luo, Li Xiong, Wenxin Li, Zhenxing Liang, Xiaobin Zheng, Liang Huang, Huashan Liu, Liang Kang
{"title":"Effects of magnetic resonance imaging prognostic factors on neoadjuvant therapy in T3 or N+ rectal cancer: A retrospective cohort study.","authors":"Hao Xie, Ziwei Zeng, Yonghua Cai, Decai Ma, Dongxu Lei, Fujin Ye, Shuangling Luo, Li Xiong, Wenxin Li, Zhenxing Liang, Xiaobin Zheng, Liang Huang, Huashan Liu, Liang Kang","doi":"10.1111/jebm.12567","DOIUrl":"10.1111/jebm.12567","url":null,"abstract":"","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":null,"pages":null},"PeriodicalIF":7.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138487742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Evidence‐Based Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1